US › Healthcare

TriSalus Life Sciences Inc. (TLSI)

US · Healthcare · Medical Devices

$4.74-0.21%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$8.9M
Revenue YoY
-2.9%
Net profit
$1.5M
Profit YoY
+114.8%
EPS
$0.03
EPS estimate
$-0.16
Net margin
17.3%

EPS came in at 0.03 against a street estimate of -0.16 — a beat of 118.4%.

Key statistics

Market cap
$278.8M
Forward P/E
0.0
P/B
21.77
Book value
$0.21
EPS (TTM)
$-1.42
52-week high
$7.95
52-week low
$2.20
50-day MA
$3.96
200-day MA
$4.78
Beta
0.43

Analyst view

Analysts rate TriSalus Life Sciences Inc. a strong buy (8 buy, 0 hold, 0 sell out of 8) with an average price target of $9.00.

Shareholding

Insiders
34.05%
Institutions
34.62%

Largest institutional holders

FundStake
First Light Asset Management, LLC8.25%
Awm Investment Company Inc3.39%
Nantahala Capital Management, LLC3.37%
Vanguard Group Inc2.49%
BlackRock Inc2.44%
Vanguard Capital Management, LLC2.19%
Gilder Gagnon Howe & CO LLC1.45%
HPM Partners LLC1.28%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for TriSalus Life Sciences Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.